XML 49 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisitions (Tables)
 12 Months Ended
Dec. 31, 2018
Schedule of Business Acquisitions, by Acquisition
The following table summarizes the preliminary purchase price allocation for the Paragon Medical acquisition.
Fair value of assets acquired and liabilities assumed as of May 7, 2018
As Reported on
June 30, 2018
 
Subsequent Adjustments to Fair Value
 
As Reported on December 31, 2018
Cash and cash equivalents
$
13,418

 
$
134

 
$
13,552

Accounts receivable
22,853

 
(721
)
 
22,132

Inventories
23,606

 
(400
)
 
23,206

Other current assets
937

 
734

 
1,671

Property, plant and equipment
69,322

 
(5,625
)
 
63,697

Intangible assets subject to amortization
164,200

 
(700
)
 
163,500

Other non-current assets
3,304

 
(129
)
 
3,175

Goodwill
157,421

 
4,399

 
161,820

Total assets acquired
$
455,061

 
$
(2,308
)
 
$
452,753

Current liabilities
$
16,767

 
$
234

 
$
17,001

Deferred tax liability
46,713

 
(2,442
)
 
44,271

Other non-current liabilities
620

 
—

 
620

Total liabilities assumed
$
64,100

 
$
(2,208
)
 
$
61,892

Net assets acquired
$
390,961

 
$
(100
)
 
$
390,861
Business Acquisition, Pro Forma Information
The provision for income taxes has also been adjusted for all periods, based upon the foregoing adjustments to historical results. The impact of adopting ASC 606 has been included based on an adoption date of January 1, 2018.
 
Year Ended December 31,
 
2018
 
2017
Pro forma net sales
$
825,891

 
$
760,772

Pro forma income (loss) from continuing operations
$
(252,268
)
 
$
3,227

Pro forma net income (loss)
$
(252,268
)
 
$
140,915

Basic income (loss) from continuing operations per share
$
(7.96
)
 
$
0.12

Diluted income (loss) from continuing operations per share
$
(7.96
)
 
$
0.12